Full Description
Nanobiomaterials and Nanomedicines for Metabolic Disorders delves into the transformative role of nanotechnology in addressing metabolic disorders. The book begins with an overview of nanoparticle classifications and then explores the synthesis of biomaterials and drug delivery systems. In addition, it explores innovative diagnostic and imaging techniques while presenting cutting-edge therapeutic approaches. Later chapters focus on specific metabolic disorders, such as cardiovascular and lifestyle-related conditions. The book is tailored to researchers, students, and healthcare professionals seeking advanced theranostic approaches to these disorders. By bridging nanotechnology with metabolic pathways, the text offers insights into how targeted nanomedicines can improve therapeutic outcomes.
Contents
Section I: Nanomedicines for metabolic disorders: drug delivery
1. Clinical use of inorganic and organic nanoparticles in metabolic syndromes
2. Application of nanomedicines in mitigating oxidative stress
3. Nanomedicines to enhance oral bioavailability for metabolic disorders
4. Nanotechnology for the therapeutic use of biologics to treat metabolic disorders
Section II: Nanotechnology in metabolic disorders: diagnosis and therapy
5. Application of quantum dots in metabolic disorders
6. Medical imaging using nanotechnology
7. Nanorobotics: applications in metabolic disorders
8. Nanomaterials for three-dimensional printing in management of metabolic disorders
Section III: Nanomedicines for lifestyle metabolic disorders
9. Nanomedicines to alleviate hepatic metabolic disorders
10. Role of nanomedicines in type 2 diabetes
11. Nanomedicines for precise therapy in hyperlipidaemia & obesity
Section IV: Nanomedicines for cellular metabolic disorders
12. Application of nanotechnology in lysosomal storage diseases
13. Nanotechnology to target autophagy-mediated metabolic disorders
14. Application of nanomedicines in glycogen storage diseases
Section V: Nanomedicines for metabolic cardiovascular diseases
15. Nanotechnology for metabolic vascular diseases
16. Nanomedicines for the management of atherosclerosis
